biote Corp. (BTMD)
5.87
0.20 (3.53%)
At close: Jan 15, 2025, 11:08 AM
Company Description
biote Corp. operates in medical practice-building business within the hormone optimization space.
The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women.
The company was founded in 2011 and is headquartered in Irvine, Texas.
biote Corp.
| Country | United States |
| IPO Date | Apr 28, 2021 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 194 |
| CEO | Teresa S. Weber |
Contact Details
Address: 1875 West Walnut Hill Lane Irving, Texas United States | |
| Website | https://biote.com |
Stock Details
| Ticker Symbol | BTMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819253 |
| CUSIP Number | 090683103 |
| ISIN Number | US0906831039 |
| Employer ID | 85-1791125 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Teresa S. Weber | Chief Executive Officer & Director |
| James Elliott Gibbs II | Chief People Officer |
| John J. Olsen | Chief Information Officer |
| Robert C. Peterson | Chief Financial Officer |
| Dr. Cory Rice D.O. | Chief Clinical Advisor & Member of Medical Advisory Board |
| Jade Beutler | Head of Nutraceuticals |
| Marc D. Beer | Executive Chairman |
| Mary Elizabeth Conlon | Vice President of Business Development, General Counsel & Corporate Secretary |
| Richard Kevin Key | Chief Digital Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | 424B3 | Filing |
| Nov 13, 2024 | 424B3 | Filing |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 22, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 11, 2024 | 4 | Filing |
| Aug 09, 2024 | 424B3 | Filing |
| Aug 09, 2024 | 424B3 | Filing |
| Aug 09, 2024 | 10-Q | Quarterly Report |